Myocardial alternative RNA splicing and gene expression profiling in early stage hypoplastic left heart syndrome.
Myocardial alternative RNA splicing and gene expression profiling in early stage hypoplastic left heart syndrome.
复制标题
DOI:
10.1371/journal.pone.0029784
复制
发表时间:
2012
期刊:
影响因子:
3.7
通讯作者:
Lincoln J
中科院分区:
文献类型:
--
作者:
Ricci M;Xu Y;Hammond HL;Willoughby DA;Nathanson L;Rodriguez MM;Vatta M;Lipshultz SE;Lincoln J
Hypoplastic Left Heart Syndrome (HLHS) is a congenital defect characterized by underdevelopment of the left ventricle and pathological compensation of the right ventricle. If untreated, HLHS is invariably lethal due to the extensive increase in right ventricular workload and eventual failure. Despite the clinical significance, little is known about the molecular pathobiological state of HLHS. Splicing of mRNA transcripts is an important regulatory mechanism of gene expression. Tissue specific alterations of this process have been associated with several cardiac diseases, however, transcriptional signature profiles related to HLHS are unknown. In this study, we performed genome-wide exon array analysis to determine differentially expressed genes and alternatively spliced transcripts in the right ventricle (RV) of six neonates with HLHS, compared to the RV and left ventricle (LV) from non-diseased control subjects. In HLHS, over 180 genes were differentially expressed and 1800 were differentially spliced, leading to changes in a variety of biological processes involving cell metabolism, cytoskeleton, and cell adherence. Additional hierarchical clustering analysis revealed that differential gene expression and mRNA splicing patterns identified in HLHS are unique compared to non-diseased tissue. Our findings suggest that gene expression and mRNA splicing are broadly dysregulated in the RV myocardium of HLHS neonates. In addition, our analysis identified transcriptome profiles representative of molecular biomarkers of HLHS that could be used in the future for diagnostic and prognostic stratification to improve patient outcome.
登录
查看更多内容
影响因子:
6
作者:
Ricci, Marco;Mohapatra, Bhagyalaxmi;Vatta, Matteo
通讯作者:
Vatta, Matteo
影响因子:
10.8
作者:
Doenst, Torsten;Pytel, Gracjan;Schwarzer, Michael
通讯作者:
Schwarzer, Michael
影响因子:
37.8
作者:
Heidecker B;Kittleson MM;Kasper EK;Wittstein IS;Champion HC;Russell SD;Hruban RH;Rodriguez ER;Baughman KL;Hare JM
通讯作者:
Hare JM
影响因子:
5.3
作者:
Georges, Romain;Nemer, Georges;Nemer, Mona
通讯作者:
Nemer, Mona
DOI:
10.1073/pnas.0801319105
发表时间:
2008-04-01
影响因子:
11.1
作者:
Einstein, Richard;Jordan, Heather;Liggett, Stephen B.
通讯作者:
Liggett, Stephen B.